USFDA APPLICATION NUMBER - 50795 / DOSAGE - TABLET, DELAYED RELEASE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
DOXYCYCLINE HYCLATE(UNII: 19XTS3T51U) (DOXYCYCLINE ANHYDROUS - UNII:334895S862) | DOXYCYCLINE ANHYDROUS | 75mg in 100 |
Inactive Ingredients
Ingredient Name | Allergan, Inc. | Mayne Pharma International Pty Ltd |
---|---|---|
ANHYDROUS LACTOSE(3SY5LH9PMK) | ||
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | ||
CROSPOVIDONE(2S7830E561) | ||
CROSPOVIDONE(68401960MK) | ||
LACTOSE MONOHYDRATE(EWQ57Q8I5X) | ||
MAGNESIUM STEARATE(70097M6I30) | ||
SODIUM CHLORIDE(451W47IQ8X) | ||
SODIUM LAURYL SULFATE(368GB5141J) | ||
STARCH, CORN(O8232NY3SJ) | ||
TALC(7SEV7J4R1U) |
LOOKING FOR A SUPPLIER?